Japan-United States of America Harmonized Assessment by Randomized Multicentre Study of OrbusNEich’s Combo StEnt (Japan-USA HARMONEE) study: primary results of the pivotal registration study of combined endothelial progenitor cell capture and drug-eluting stent in patients with ischaemic coronary disease and non-ST-elevation acute coronary syndrome-Reference-Cited by-同舟云学术

Japan-United States of America Harmonized Assessment by Randomized Multicentre Study of OrbusNEich’s Combo StEnt (Japan-USA HARMONEE) study: primary results of the pivotal registration study of combined endothelial progenitor cell capture and drug-eluting stent in patients with ischaemic coronary disease and non-ST-elevation acute coronary syndrome

Published:2018-06-21 Issue:26 Volume:39 Page:2460-2468
ISSN:0195-668X
Container-title:European Heart Journal
language:en
Short-container-title:

Author:

Saito Shigeru¹,Krucoff Mitchell W²,Nakamura Shigeru³,Mehran Roxana⁴,Maehara Akiko⁵,Al-Khalidi Hussein R²,Rowland Stephen M⁶,Tasissa Gudaye²,Morrell Debbie⁶,Joseph Diane²,Okaniwa Yumiko⁷,Shibata Yoshisato⁸,Bertolet Barry D⁹,Rothenberg Mark D¹⁰,Généreux Philippe¹¹,Bezerra Hiram¹²,Kong David F²

Affiliation:

1. Shonan Kamakura General Hospital, Kamakura, Japan, and Sapporo Higashi Tokushukai Hospital, Sapporo, Japan

2. Duke University Medical Center and Duke Clinical Research Institute, Durham, NC, USA

3. Kyoto Katsura Hospital, Kyoto, Japan

4. Mount Sinai School of Medicine, New York, NY, USA

5. Cardiovascular Research Foundation and Columbia University, New York, NY, USA

6. OrbusNeich Medical, Inc., Fort Lauderdale, FL, USA

7. OrbusNeich Japan, Tokyo, Japan

8. Miyazaki Medical Association Hospital, Miyazaki, Japan

9. Cardiology Associates of North Mississippi, Tupelo, MS, USA

10. Atlantic Clinical Research Collaborative - Cardiology, Atlantis, FL, USA

11. Morristown Medical Center, Morristown, NJ, USA

12. University Hospitals of Cleveland, Cleveland, OH, USA

Funder

OrbusNeich Medical, Inc

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/eurheartj/article-pdf/39/26/2460/25124351/ehy275.pdf

Reference21 articles.

1. Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials;Bangalore;Circulation,2012

2. Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis;Palmerini;Lancet,2012

3. Stent thrombosis in randomized clinical trials of drug-eluting stents;Mauri;N Engl J Med,2007

4. A new era of prospective real-world safety evaluation primary report of XIENCE V USA (XIENCE V Everolimus Eluting Coronary Stent System condition-of-approval post-marker study);Krucoff;JACC Cardiovasc Interv,2011

5. Isolation of putative progenitor endothelial cells for angiogenesis;Asahara;Science,1997

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of baseline yellow plaque assessed by coronary angioscopy on vascular response after stent implantation;Journal of Cardiology;2024-09

2. The Role of Progenitor Cells in the Pathogenesis of Arteriosclerosis;Cardiology Discovery;2024-08-13

3. Dual-therapy CD34 antibody-covered sirolimus-eluting COMBO stents versus sirolimus-eluting Orsiro stents in patients treated with percutaneous coronary intervention: the three-year outcomes of the SORT OUT X randomised clinical trial;EuroIntervention;2023-10

4. Contemporary coronary drug-eluting and coated stents: an updated mini-review (2023);Cardiovascular Intervention and Therapeutics;2023-09-01

5. In-stent restenosis after percutaneous coronary intervention: emerging knowledge on biological pathways;European Heart Journal Open;2023-08-24